
Company Info
Year Established2017
Contacts
Marcel Frenkel, PhDCo-Founder & CEO
Company Description
Ten63 Therapeutics is leveraging its BEYOND computational platform for generative chemistry to develop first- and best-in-class therapeutics. The company is progressing an internal pipeline focused on oncology while pursuing select and strategic partnerships in multiple indications.